drug
emtricitabine
Marketedupdated 6mo agoby $GILD GILEAD SCIENCES, INC.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6- drugEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE12 co-mentions · 3 sources
- drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE12 co-mentions · 3 sources
- tagApproval12 co-mentions · 3 sources
- tagSmall Molecule6 co-mentions · 3 sources
- drugtenofovir alafenamide4 co-mentions · 2 sources
- drugTENOFOVIR DISOPROXIL FUMARATE2 co-mentions · 1 sources
all catalysts(2)
Trials studying emtricitabine
- phase3Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
- —Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- phase3A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
- phase4Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women
- phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
- phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
- phase4REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
- phase3A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that